Abstract

This study delves into the intricate interplay between Vitamin E supplementation and Angiotensin Receptor Antagonists (ARA) in shaping cardiovascular health. By exploring their individual impacts and scrutinizing their combined influence, we aim to unravel potential synergistic effects that may offer novel insights into cardiovascular disease management. The research integrates clinical data, molecular analyses, and experimental models to comprehensively assess the intricate mechanisms at play. Ultimately, our findings aspire to contribute to a more nuanced understanding of cardiovascular health interventions and pave the way for targeted strategies that capitalize on the synergistic potential of Vitamin E and Angiotensin Receptor Antagonists.